One of the Best Biotech Stocks of 2018 so Far

The biotech sector has been known to produce enormous profits for investors. Some of The Cheap Investor’s superstar winners include: ACADIA Pharmaceuticals skyrocketed 4,851% Bradley Pharmaceuticals jumped more than 2,951% Celator Pharmaceuticals was up 1,635% Vanda Pharmaceuticals soared 2,467% Those are life-changing returns… And opportunities for similar fortunes are there for the taking. In fact,…

Details

This Biotech Stock may Have Another 200% of Upside, Near-Term

Over the last few years, we’ve watched small-cap stocks explode. Vanda Pharmaceuticals ran up 2,467% ACADIA Pharmaceuticals returned 4,851% Bradley Pharmaceuticals was up more than 2,951% Celator Pharmaceuticals exploded 1,635% In many cases, each was wrongly ignored, despite underlying fundamental strength. But as we’ve learned over the years, ignoring a stock can be costly, despite…

Details

How to Earn 1,556% during Market Volatility

New tarriffs have caused extreme volatility in the markets. But a handful of sectors are still thriving, including biotech stocks, thanks to booming merger and acquisition activity, an aging population, and impressive new innovations. Look at Mirati Therapeutics (MRTX), which is a clinical-stage oncology company developing targeted product candidates to address the genetic, epigenetic and…

Details